Literature DB >> 30048690

High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations.

Akihiro Hoshino1, Kay Tanita1, Kenji Kanda2, Ken-Ichi Imadome3, Yoshiaki Shikama4, Takahiro Yasumi5, Kohsuke Imai6, Masatoshi Takagi1, Tomohiro Morio1, Hirokazu Kanegane7.   

Abstract

Patients with CTLA4 mutations present with autoimmune diseases, lymphoproliferation, and hypogammaglobulinemia, and a subset of patients developed Epstein-Barr virus (EBV)-associated malignancies, suggesting an impaired immune function against EBV. Here we investigated EBV infection in individuals with CTLA4 mutations. We measured EBV viral DNA in healthy individuals, individuals with autoimmune diseases, and individuals with CTLA4 mutations. In addition, we evaluated the numbers and function of EBV-specific T cells, invariant NKT cells, and NK cells. More than half of individuals with CTLA4 mutations including asymptomatic ones had detectable EBV DNA, which is a significantly higher frequency with higher viral loads compared with healthy and disease controls. However, individuals with CTLA4 mutations had almost normal immunity against EBV. Individuals with CTLA4 mutations have an increased susceptibility to Epstein-Barr virus infections. Asymptomatic viremia occurs at high frequencies, which can be persistent and can occur in unaffected individuals.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asymptomatic viremia; CTLA4 deficiency; Epstein–Barr virus

Mesh:

Substances:

Year:  2018        PMID: 30048690     DOI: 10.1016/j.clim.2018.07.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

1.  Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study.

Authors:  Jessica Rojas-Restrepo; Andrés Caballero-Oteyza; Katrin Huebscher; Hanna Haberstroh; Manfred Fliegauf; Baerbel Keller; Robin Kobbe; Klaus Warnatz; Stephan Ehl; Michele Proietti; Bodo Grimbacher
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

2.  Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study.

Authors:  Akihiro Hoshino; Etsushi Toyofuku; Noriko Mitsuiki; Motoi Yamashita; Keisuke Okamoto; Michio Yamamoto; Kenji Kanda; Genki Yamato; Dai Keino; Yuri Yoshimoto-Suzuki; Junji Kamizono; Yasuhiro Onoe; Takuya Ichimura; Mika Nagao; Masaru Yoshimura; Koji Tsugawa; Toru Igarashi; Kanako Mitsui-Sekinaka; Yujin Sekinaka; Takehiko Doi; Takahiro Yasumi; Yozo Nakazawa; Masatoshi Takagi; Kohsuke Imai; Shigeaki Nonoyama; Tomohiro Morio; Sylvain Latour; Hirokazu Kanegane
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

3.  A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Authors:  Hepei Yuan; Momoko Nishikori; Chiyoko Ueda; Masakazu Fujimoto; Takahiro Yasumi; Yasuyuki Otsuka; Toshio Kitawaki; Masahiro Hirata; Hironori Haga; Hirokazu Kanegane; Akifumi Takaori-Kondo
Journal:  J Clin Exp Hematop       Date:  2021-10-26

4.  Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers.

Authors:  David Egg; Charlotte Schwab; Annemarie Gabrysch; Peter D Arkwright; Edmund Cheesman; Lisa Giulino-Roth; Olaf Neth; Scott Snapper; Satoshi Okada; Michel Moutschen; Philippe Delvenne; Ann-Christin Pecher; Daniel Wolff; Yae-Jean Kim; Suranjith Seneviratne; Kyoung-Mee Kim; Ji-Man Kang; Samar Ojaimi; Catriona McLean; Klaus Warnatz; Maximilian Seidl; Bodo Grimbacher
Journal:  Front Immunol       Date:  2018-09-10       Impact factor: 7.561

Review 5.  Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.

Authors:  Neelakshi R Jog; Judith A James
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

Review 6.  Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection.

Authors:  Christian Münz
Journal:  Biomolecules       Date:  2021-12-28

Review 7.  Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.

Authors:  Tarin M Bigley; Megan A Cooper
Journal:  Curr Opin Immunol       Date:  2021-07-12       Impact factor: 7.268

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.